Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 497 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

NCT02460224

Conditions
Adenoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Columbia University Medical Center SC LAG X2101C New York, United States
  • Memorial Sloan Kettering Cancer Center SC New York, United States
  • Duke Clinical Research Institute SC Durham, North Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 24 locations
View Trial Details
Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

NCT02381314

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Safety Study of MGA271 in Refractory Cancer

NCT01391143

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +49 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions